Product NDC: | 54458-997 |
Proprietary Name: | Lisinopril |
Non Proprietary Name: | Lisinopril |
Active Ingredient(s): | 10 mg/1 & nbsp; Lisinopril |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54458-997 |
Labeler Name: | International Labs, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077321 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080201 |
Package NDC: | 54458-997-10 |
Package Description: | 30 TABLET in 1 BLISTER PACK (54458-997-10) |
NDC Code | 54458-997-10 |
Proprietary Name | Lisinopril |
Package Description | 30 TABLET in 1 BLISTER PACK (54458-997-10) |
Product NDC | 54458-997 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lisinopril |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20080201 |
Marketing Category Name | ANDA |
Labeler Name | International Labs, Inc. |
Substance Name | LISINOPRIL |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |